[1] [1] C. D. Ellison, B. J. Ennis, M. L. Hamad, R. C. Lyon, "Measuring the distribution of density and tabletting force in pharmaceutical tablets by chemical imaging," J. Pharm. Biomed. 48, 1–7 (2008).

[2] [2] J. M. Amigo, C. Ravn, "Direct quantification and distribution assessment of major and minor components in pharmaceutical tablets by NIR-chemical imaging," Eur. J. Pharm. Sci. 37, 76–82 (2009).

[3] [3] C. Ravn, E. Skibsted, R. Bro, "Near-infrared chemical imaging (NIR-CI) on pharmaceutical solid dosage forms-comparing common calibration approaches," J. Pharm. Biomed. 48, 554–561 (2008).

[4] [4] M. B. Lopes, J. C. Wolff, J. M. Bioucas-Dias, M. A. T. Figueiredo, "Quantification of components in non-homogenous pharmaceutical tablets using near infrared reflectance imaging," J. Near Infrared Spectrosc. 18, 333–340 (2010).

[5] [5] G. Sando, J. Dubois, "Seeing the chemicals in pharmaceutical tablets with NIR chemical imaging," Chim. Oggi 28, 40–42 (2010).

[6] [6] J. Cruz, M. Bautista, J. M. Amigo, M. Blanco, "NIR-chemical imaging study of acetylsalicylic acid in commercial tablets," Talanta 80, 473–478 (2009).

[7] [7] L. R. Hilden, C. J. Pommier, S. I. F. Badawy, E. A. Friedman, "NIR chemical imaging to guide/support BMS-561389 tablet formulation development," Int. J. Pharm. 353, 283–290 (2008).

[8] [8] R. P. Anil, D. C. Pravin, "Novel techniques for solubility, dissolution rate and bioavailability enhancement of class II and IV drugs," Asian J. Biomed. Pharm. Sci. 2, 9–14 (2012).

[9] [9] X. P. Huang, X. X. Wan, Q. Liu, "Relationship between dissolution rate and bioavailability of paracetamol tablet," Di Yi Jun Yi Da Xue Xue Bao 23, 367–371 (2003).

[10] [10] A. S. El-Hagrasy, H. R. Morris, F. D'amico, R. A. Lodder, J. K. Drennen, "Near-Infrared spectroscopy and imaging for the monitoring of powder blend homogeneity," J. Pharm. Sci. 90, 1298–1307 (2001).

[11] [11] Y. Roggo, N. Jent, A. Edmond, "Characterizing process effects on pharmaceutical solid forms using near-infrared spectroscopy and infrared imaging," Eur. J. Pharm. Biopharm. 61, 100–110 (2005).

[12] [12] M. Saravanan, K. S. Nataraj, K. S. Ganesh, "The effect of tablet formulation and hardness on in vitro release of cephalexin from Eudragit L100 based extended release tablets," Biol. Pharm. Bull. 25, 541– 545 (2002).

[13] [13] Z. Wu, O. Tao, W. Cheng, L. Yu, X. Shi, Y. Qiao, "Visualizing excipient composition and homogeneity of Compound Liquorice Tablets by near-infrared chemical imaging," Spectrochim. Acta A 86, 631– 636 (2012).

[14] [14] Z. Wu, O. Tao, W. Cheng, L. Yun, X. Shi, Y. Qiao, "Research on spatial distribution and composition uniformity of Rukuaixiao tablets intermediate by spectral imaging," Chin J. Anal. Chem. 5, 628–634 (2011).

[15] [15] Z. Wu, O. Tao, X. Dai, M. Du, X. Shi, Y. Qiao, "Monitoring of a pharmaceutical blending process using near infrared chemical imaging," Vib. Spectrosc. 63, 371–379 (2012).

[16] [16] Y. Luo, R. Li, W. He, "Selection of excipients for Yinhuang dispersible tablets by uniform design," Acad. J. Guangdong College Pharm. 20, 117–119 (2004).

[17] [17] L. Zhou, Z. Wu, X. Shi, M. Xu, B. Xu, Y. Qiao, "Rapid discrimination of chlorpheniramine maleate and assessment of its surface content uniformity in a pharmaceutical formulation by NIR-CI coupled with statistical measurement," Spectroscopy (2014), doi:10.1155/2014/741246.